Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MicroRNA Blocks Proapoptotic Genes in Mature Nerve Cells

By LabMedica International staff writers
Posted on 08 Feb 2011
A microRNA (miRNA) has been identified that blocks the activity of proapoptotic proteins in mature nerve cells and may be a potential drug for the treatment of neurodegenerative disorders.

During development, nerve cells that fail to connect to target tissues self-destruct. More...
Yet, once such connections are made, surviving neurons become resistant to apoptosis for the life span of the organism.

Investigators at the University of North Carolina (Chapel Hill, USA) studied the mechanism underlying this radical change in behavior. They considered the class of gene-regulating molecules known as microRNAs to be a particularly promising target. To this end, they screened all known miRNAs to identify differences between immature and mature neurons.

Results published in the January 15, 2011, online edition of the journal Genes & Development revealed that the microRNA miR-29 was markedly induced with neuronal maturation. Immature neurons that would normally die became resistant to apoptosis following exposure to miR-29. Furthermore, analysis of brain tissues from patients with Alzheimer's disease or Huntington's disease showed reduced levels of miR-29.

The investigators reported that at the molecular level miR-29 blocked the activity of the genes that encode the BH3-only proapoptotic protein family. MiR-29 was able to inhibit several of these genes, circumventing a redundancy that allowed apoptosis to continue even if one of them had been blocked.

"There is the real possibility that this molecule could be used to block the cascade of events known as apoptosis that eventually causes brain cells to break down and die,” said senior author Dr. Mohanish Deshmukh, associate professor of cell and developmental biology at the University of North Carolina.

"People in the field have been perplexed that when they have knocked-out any one of these members it has not had a remarkable effect on apoptosis because there are others that can step in and do the job,” said Dr. Deshmukh. "The fact that this microRNA can target multiple members of this family is very interesting because it shows how a single molecule can basically in one stroke keep apoptosis from happening. Interestingly, it only targets the members that are important for neuronal apoptosis, so it may be a way of specifically preserving cells in the brain without allowing them to grow out of control (and cause cancer) elsewhere in the body.”

Related Links:
University of North Carolina


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.